Featured Post

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...

Wednesday, May 24, 2017

Protagonist Therapeutics Receives $1.34 Million SBIR Funding for Development of Biomarkers of IL-23 Receptor Antagonist Activity

http://ift.tt/2qKb1qO

Protagonist Therapeutics, Inc. (PRNewsFoto/Protagonist Therapeutics, Inc.)NEWARK, Calif., May 24, 2017 /PRNewswire/ — Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced the receipt of a Phase 2 Small Business Innovation Research (SBIR) Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes…

May 24, 2017 at 05:31PM

http://ift.tt/2qVQeBW

from

http://ift.tt/2qVQeBW


Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)